Clinical Trials Browser

Phase 1/2 × NETWORK × Lenalidomide × Clear all

NCT01460420 2017-07-06

EMN-alloRIC

Phase 1/2 Completed

Other hematologic neoplasmPlasma cell

Multiple Myeloma, Hematologic Neoplasms